Trending Now
Incyte (NASDAQ:INCY) Releases Phase 2 POD1UM-202 Trial Results Of Retifanlimab in...
Incyte (NASDAQ:INCY) has announced the Phase 2 POD1UM-202 study result for the evaluation of retifanlimab, its PD-1 inhibitor in treating patients with advanced squamous...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Canopy Growth Corp (NYSE:CGC) technical alert
Yesterday’s selloff caught a few folks off guard. Its broad base didn’t really spare anyone, except for cannabis stocks. One, in particular,...
MAKE IT MODERN
LATEST REVIEWS
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) Finalizes RESOLVE-1 Third Phase Lenabasum Study...
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) has announced that the last subject in its RESOLVE-1 third phase lenabasum study for systemic sclerosis treatment has competed...
MAKE IT MODERN
PERFORMANCE TRAINING
Voyager Therapeutics Inc. (NASDAQ: VYGR) And Pfizer Inc. (NYSE: PFE) Enter Deal For Licensing...
Voyager Therapeutics Inc. (NASDAQ: VYGR) has announced a deal through which Pfizer Inc. (NYSE: PFE) could license novel capsids generated from the company’s RNA-driver...
Clovis Oncology Inc. (NASDAQ:CLVS) Announces NCCN’s Updated Guidelines To Include Rubraca Tablets As A...
Clovis Oncology Inc. (NASDAQ:CLVS) has announced that Rubraca (rucaparib) tablets have been approved for the treatment of BRCA-mutant mCRPC in a second-line setting as...
Small Cap MMA Stock B2Digital (BTDG) Deep Dive: Apple iPhone Event Set for this...
How undervalued are shares of B2Digital Inc (OTC US:BTDG) right now?
The stock is trading at a market cap...
Wall Street’s Top Stock Picks for the Week: From Tesla (TSLA) to Getty (GETTY)
As we navigate through another bustling week on Wall Street, several major analysts and banks have made significant calls regarding some...
NextCure Inc (NASDAQ:NXTC) Releases Interim Data From Its Phase 1/2 Monotherapy Study Of NC318
NextCure Inc (NASDAQ:NXTC) recently released interim findings from its phase 1/2 Monothapy clinical study evaluating NC318.
The company revealed that it has decided not to...
MAKE IT MODERN
